Fully funded postdoctoral research positions are available in Dr. Michael Aregger’s Functional Genomics Section within the Molecular Targets Program at the National Cancer Institute (NCI) at the National Institutes of Health (NIH) in Frederick, MD, USA. The group’s research focuses on how cancer cells rewire gene expression and metabolism to adapt to changing environmental conditions. Towards this Michael Aregger’s group applies CRISPR-based genome engineering tools and functional genomics approaches to reveal genetic interactions and cancer dependencies, and to identify regulators of metabolic plasticity in cancer cells. For more information about our research, please visit our website: https://ccr.cancer.gov/molecular-targets-program/michael-b-aregger
Applicants should send a brief cover letter, CV including bibliography, and contact information of three references to Michael Aregger: firstname.lastname@example.org
The Aregger lab is part of NCI’s Center for Cancer Research (CCR). CCR offers fellows access to cutting-edge technologies and cores, a highly collaborative environment, awards and research forums to recognize outstanding postdocs, continuous scientific symposia and lectures featuring leading researchers, a strong commitment to translational research, and a vibrant clinical research program housed in the world’s largest dedicated research hospital, the NIH Clinical Center. Read more about CCR, the benefits of working at CCR and hear from our staff on their CCR experiences:
Frederick is the second largest city in Maryland but retains a “small town” feel, surrounded by mountain views with a vibrant Main Street community. The city offers outstanding schools, a balanced and thriving economy and a highly educated workforce.
Applicants must have a Ph.D. degree and expertise in molecular biology, genetics, biochemistry, cell biology or bioinformatics. Motivated candidates who are interested in innovative research using cutting-edge technologies are encouraged to apply. Applicants with research experience in functional genomics, CRISPR technology, molecular biology and bioinformatics are especially encouraged to apply.
About National Cancer Institute (NCI)
The Center for Cancer Research (CCR) is home to nearly 250 basic and clinical research groups located on two campuses just outside of Washington, D.C. CCR is part of the National Cancer Institute (NCI) and makes up the largest component of the research effort at the National Institutes of Health (NIH). Centrally supported by long-term funding and a culture of complete intellectual freedom, CCR scientists are able to pursue the most important and challenging problems in cancer research. We collaborate with academic and commercial partners and advocacy groups across the world in efforts to prevent, diagnose and treat cancer and HIV/AIDS. The CCR research portfolio covers the full spectrum of biological and biomedical research. Our work ranges from basic to translational and clinical, and our clinical trials are conducted in the NIH Clinical Center, the world’s largest hospital dedicated to clinical research that offers a robust infrastructure to support CCR’s patients on an estimated 250 open studies. The success of CCR is grounded in an exceptionally strong discovery research program that provides the foundation for the seamless translation of insights from bench to bedside. Read more about CCR, the benefits of working at CCR and hear from our staff on their CCR experiences.